Please login to the form below

Not currently logged in
Email:
Password:

bapineuzumab

This page shows the latest bapineuzumab news and features for those working in and with pharma, biotech and healthcare.

Biogen investigating death linked to Aduhelm

Biogen investigating death linked to Aduhelm

as a treatment for Alzheimer’s, bapineuzumab.

Latest news

More from news
Approximately 1 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Interview: Mike Hutton, Lilly Interview: Mike Hutton, Lilly

    Work on Pfizer, J&J and Elan's bapineuzumab, Lundbeck/Myriad Genetics' Flurizan, Pfizer and Medivation's Dimebon (latrepirdine), to name a few, has come to a halt in recent years.

  • Interview: Cesar Rodriguez, Janssen Interview: Cesar Rodriguez, Janssen

    And despite recent disappointments involving Alzheimer's candidate bapineuzumab, the company is still committed to tackling the “huge unmet medical need” of the condition, according to Rodriguez.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....